Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cubicin vs Vancomycin in Home Infusion for cSSSI
NCT01175707Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2010
- Primary completion
- Nov 2011
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in Complicated skin and skin structure infection (cSSSI), sponsored by Merck & Co.. Started Jul 2010; status: terminated.
02
Drugs
daptomycin
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on NCT01175707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175707.